February 27, 2020

Bayer reaches agreement with stockholder Prof. Strenger on voluntary special audit of due diligence procedures

more

February 27, 2020

Fiscal 2019:

Bayer strategically and operationally successful

more

February 26, 2020

Personnel changes after Annual Stockholders' Meeting on April 28, 2020:

Norbert Winkeljohann to succeed Werner Wenning as Chairman of Bayer's Supervisory Board

more

February 17, 2020

Bayer to swiftly appeal jury decision in dicamba case

more

February 13, 2020

Bayer Driving Agricultural Innovation and Sustainability with Industry-Leading Pipeline and Investment

more

February 10, 2020

Not intended for U.S. and UK Media

Bayer announces Phase III trials with new aflibercept 8mg formulation

more

January 31, 2020

Bayer Welcomes U.S. Environmental Protection Agency's Reaffirmation that Glyphosate Is Safe to Use, Not Carcinogenic

more

January 31, 2020

Not intended for U.S. and UK Media

Bayer receives positive CHMP opinion for darolutamide as a new treatment for men with non-metastatic castration-resistant prostate cancer

more

January 30, 2020

Not intended for U.S. and UK Media - Updated results of Phase III trial show:

Darolutamide plus androgen deprivation therapy significantly increased overall survival in men with non-metastatic castration-resistant prostate cancer

more

January 23, 2020

Not intended for U.S. and UK Media

Bayer submits application to European Medicines Agency for pre-filled syringe to administer eye medication Eylea®

more